Good long-term results of sacral neuromodulation for endometriosis related chronic pelvic pain.

IF 2.4 3区医学 Q2 OBSTETRICS & GYNECOLOGY

BMC Women's Health Pub Date : 2025-04-07 DOI:10.1186/s12905-025-03699-y

Adrian Zegrea, Emilia Ojala, Jaan Kirss, Pia Suvitie, Pirita Varpe, Johanna Mäkelä-Kaikkonen, Tero Rautio, Jaana Seikkula, Mika Ukkonen, Maija Lavonius, Tarja Pinta

{"title":"Good long-term results of sacral neuromodulation for endometriosis related chronic pelvic pain.","authors":"Adrian Zegrea, Emilia Ojala, Jaan Kirss, Pia Suvitie, Pirita Varpe, Johanna Mäkelä-Kaikkonen, Tero Rautio, Jaana Seikkula, Mika Ukkonen, Maija Lavonius, Tarja Pinta","doi":"10.1186/s12905-025-03699-y","DOIUrl":null,"url":null,"abstract":"Background: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good results in patients with chronic pelvic pain (CPP). Our aim was to analyze long-term results of SNM in Finnish patients with endometriosis related CPP.Methods: This is a register-based retrospective study including all the endometriosis patients treated with SNM for CPP in Finland between 2004 and 2017. There were four centers where these procedures were performed, two University Hospitals and two Central Hospitals. Long-term results were assessed by phone interview in spring 2021.Results: A total of 16 women with endometriosis, with a median age of 39 (25-50) years, underwent SNM treatment for chronic pelvic pain (CPP), with the median follow-up time of 73 (48-85) months. The Implantable Pulse Generator (IPG) was implanted to 14 patients (88%). By the end of the follow-up period, 10 patients (62,5% of all patients and 71% of those who received IPG) had a functional SNM. Pain was assessed by numeral rating scale (NRS) and decreased from a median of 7.4 (3.6-10) to 2.3 (0-6.5).Conclusions: SNM could be a good option in the treatment of endometriosis related chronic pelvic pain when standard therapy is not enough.","PeriodicalId":9204,"journal":{"name":"BMC Women's Health","volume":"25 1","pages":"162"},"PeriodicalIF":2.4000,"publicationDate":"2025-04-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11974166/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"BMC Women's Health","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1186/s12905-025-03699-y","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}

引用次数: 0

Abstract

Background: Sacral neuromodulation (SNM) is an established therapy in urology and gastroenterological surgery for treatment of overactive bladder symptoms, urge urinary incontinence or fecal incontinence. SNM has also been used with good results in patients with chronic pelvic pain (CPP). Our aim was to analyze long-term results of SNM in Finnish patients with endometriosis related CPP.

Methods: This is a register-based retrospective study including all the endometriosis patients treated with SNM for CPP in Finland between 2004 and 2017. There were four centers where these procedures were performed, two University Hospitals and two Central Hospitals. Long-term results were assessed by phone interview in spring 2021.

Results: A total of 16 women with endometriosis, with a median age of 39 (25-50) years, underwent SNM treatment for chronic pelvic pain (CPP), with the median follow-up time of 73 (48-85) months. The Implantable Pulse Generator (IPG) was implanted to 14 patients (88%). By the end of the follow-up period, 10 patients (62,5% of all patients and 71% of those who received IPG) had a functional SNM. Pain was assessed by numeral rating scale (NRS) and decreased from a median of 7.4 (3.6-10) to 2.3 (0-6.5).

Conclusions: SNM could be a good option in the treatment of endometriosis related chronic pelvic pain when standard therapy is not enough.

查看原文本刊更多论文

骶神经调节治疗子宫内膜异位症相关慢性盆腔疼痛的长期良好效果。

背景：骶神经调节（SNM）是泌尿外科和胃肠外科治疗膀胱过动症、急迫性尿失禁或大便失禁的常用疗法。SNM也用于慢性盆腔疼痛（CPP）患者，效果良好。我们的目的是分析芬兰子宫内膜异位症相关CPP患者SNM的长期结果。方法：这是一项基于登记的回顾性研究，包括2004年至2017年在芬兰接受SNM治疗的所有子宫内膜异位症患者。有四个中心进行这些手术，两个大学医院和两个中心医院。2021年春季通过电话访谈评估长期结果。结果：共有16例子宫内膜异位症患者接受了SNM治疗慢性盆腔疼痛（CPP），中位年龄39（25-50）岁，中位随访时间73（48-85）个月。植入式脉冲发生器（IPG）植入14例（88%）。随访结束时，10例患者（62.5%的患者和71%的接受IPG治疗的患者）出现功能性SNM。疼痛通过数字评定量表（NRS）进行评估，从7.4（3.6-10）的中位数下降到2.3（0-6.5）。结论：在标准治疗不充分的情况下，SNM是治疗子宫内膜异位症相关慢性盆腔疼痛的良好选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

BMC Women's Health OBSTETRICS & GYNECOLOGY-

CiteScore

3.40

自引率

4.00%

发文量

444

审稿时长

>12 weeks

期刊介绍： BMC Women''s Health is an open access, peer-reviewed journal that considers articles on all aspects of the health and wellbeing of adolescent girls and women, with a particular focus on the physical, mental, and emotional health of women in developed and developing nations. The journal welcomes submissions on women''s public health issues, health behaviours, breast cancer, gynecological diseases, mental health and health promotion.